Q4 2025 · 13F-HR
FCPM III SERVICES B.V.holdings as filed
Filed 2026-02-17 · accession 0001193125-26-053151
$762.9M
Reported value
10
Positions
2025-12-31
Period end
The Brief · FCPM III SERVICES B.V. · Q4 2025
AI · grounded in 13F
FCPM III SERVICES B.V. established a new position in MPLT valued at $56.67M. The fund also opened a new position in CBIO for $19.9M and increased its holdings in VOR by 852.8% and RAPT by 432.6%. These additions offset the closure of its position in CATBUSD, which resulted in a $29.9M reduction.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $322.7M | 42.3% | 9,198,900 | Common | SHARED |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $106.9M | 14.0% | 5,462,846 | Common | SHARED |
| 29286M105 | — | ENGENE HOLDINGS INC | $87.0M | 11.4% | 9,632,561 | Common | SHARED |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $62.1M | 8.14% | 1,833,333 | Common | SHARED |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $56.7M | 7.43% | 3,226,400 | Common | SHARED |
| 929033207 | VOR | VOR BIOPHARMA INC | $47.3M | 6.20% | 3,617,354 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $27.3M | 3.58% | 2,808,368 | Common | SHARED |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $24.6M | 3.22% | 3,468,430 | Common | SHARED |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $19.9M | 2.61% | 1,677,852 | Common | SHARED |
| 29286M113 | — | ENGENE HOLDINGS INC | $8.5M | 1.12% | 2,878,148 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.